Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis

Journal of Neurochemistry
Zhongling ZhuZhao Yan

Abstract

Glutathione (GSH) and GSH-related enzymes constitute the most important defense system that protects cells from free radical, radiotherapy, and chemotherapy attacks. In this study, we aim to explore the potential role and regulatory mechanism of the GSH redox cycle in drug resistance in glioblastoma multiforme (GBM) cells. We found that temozolomide (TMZ)-resistant glioma cells displayed lower levels of endogenous reactive oxygen species and higher levels of total antioxidant capacity and GSH than sensitive cells. Moreover, the expression of glutathione reductase (GSR), the key enzyme of the GSH redox cycle, was higher in TMZ-resistant cells than in sensitive cells. Furthermore, silencing GSR in drug-resistant cells improved the sensitivity of cells to TMZ or cisplatin. Conversely, the over-expression of GSR in sensitive cells resulted in resistance to chemotherapy. In addition, the GSR enzyme partially prevented the oxidative stress caused by pro-oxidant L-buthionine -sulfoximine. The modulation of redox state by GSH or L-buthionine -sulfoximine regulated GSR-mediated drug resistance, suggesting that the action of GSR in drug resistance is associated with the modulation of redox homeostasis. Intriguingly, a trend toward shorte...Continue Reading

References

Jun 7, 2000·Proceedings of the National Academy of Sciences of the United States of America·E C Holland
Jun 24, 2003·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Danyelle M TownsendHaim Tapiero
Jul 17, 2003·ANZ Journal of Surgery·Heather JefferiesJohn C Hall
Oct 25, 2003·Oncogene·Tito Fojo, Susan Bates
May 26, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Helene PelicanoPeng Huang
Sep 24, 2004·Cell Biochemistry and Function·Ganesaratnam K BalendiranDeborah Fraser
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
Nov 3, 2007·Genes & Development·Frank B FurnariWebster K Cavenee
Nov 16, 2010·Current Opinion in Chemical Biology·Kenneth D Tew, Danyelle M Townsend
May 12, 2011·Free Radical Biology & Medicine·Kenneth D TewDanyelle M Townsend
Jul 28, 2011·International Journal of Cancer. Journal International Du Cancer·Amit K Maiti
Jul 29, 2011·Bioorganic & Medicinal Chemistry Letters·Reşit ÇakmakGiray Topal
Aug 5, 2011·Drugs·Alberto J Montero, Jacek Jassem
Sep 6, 2011·Oncogene·L GalluzziG Kroemer
Nov 30, 2011·Current Molecular Pharmacology·Jihong ZhangTracey D Bradshaw
Dec 6, 2011·Biochemical Pharmacology·Donald S BackosPhilip Reigan
Jan 10, 2012·Neurochemical Research·Catherine P HaarNaren L Banik
May 19, 2012·Expert Review of Anticancer Therapy·Tor-Christian Aase Johannessen, Rolf Bjerkvig
Nov 9, 2012·Neuro-oncology·Michael WellerWolfgang Wick
Feb 26, 2013·Biochemical Pharmacology·Magali Rebucci, Carine Michiels
Jun 15, 2013·Oxidative Medicine and Cellular Longevity·Nicola TraversoCinzia Domenicotti
Sep 4, 2013·Nature Reviews. Clinical Oncology·Elizabeth A KuczynskiRobert S Kerbel
Sep 26, 2013·Nature Reviews. Cancer·Caitriona HolohanPatrick G Johnston
Feb 26, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jackson D HamiltonChristiane Matuschek
Aug 1, 2014·The Lancet Oncology·Michael WellerUNKNOWN European Association for Neuro-Oncology (EANO) Task Force on Malignant Glioma
Oct 7, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jinlong ShiJian Chen

❮ Previous
Next ❯

Citations

Jul 11, 2019·Cancers·Vinee PurohitCostas A Lyssiotis
Oct 1, 2019·Physiology International·D N NandakumarK Goswami
Feb 8, 2019·Current Protein & Peptide Science·Arunaksharan NarayanankuttyVinayak Narayanankutty
Jul 2, 2020·Cancers·Dilip NarayananDennis Özcelik
Mar 7, 2020·Metabolites·Miroslava Čuperlović-CulfJagdeep K Sandhu
Jul 14, 2020·Frontiers in Oncology·Zhifang HuXingchun Gao
Jan 14, 2020·Journal of Oncology·Yunseo WooYu-Jin Jung
Apr 9, 2020·Frontiers in Pharmacology·Jiabei ZhouLushan Yu
Dec 29, 2020·Journal of Neuroscience Research·Luis Exequiel IbarraLaura Natalia Milla Sanabria
Oct 7, 2020·Journal of Photochemistry and Photobiology. B, Biology·Matías Daniel CaverzánLuis Exequiel Ibarra
Dec 5, 2020·Cells·Clarissa Ribeiro Reily RochaCarlos Frederico Martins Menck
Feb 16, 2021·Frontiers in Molecular Biosciences·Christophe OlivierFrançois M Vallette
Feb 7, 2021·International Journal of Molecular Sciences·Nadine Abdel HadiAlice Carrier
Aug 10, 2020·Life Sciences·Narges DastmalchiParisa Lotfinejad
Feb 22, 2021·Journal of Biomedical Science·Juan de Los Santos-JiménezJosé M Matés
Mar 20, 2021·Trends in Cancer·Erica PranziniMaria Letizia Taddei
Jun 26, 2021·Pharmacology & Therapeutics·Fengchao LangChunzhang Yang
Jul 19, 2021·Neurochemistry International·José A Campos-SandovalJavier Márquez
Jul 25, 2021·Nanomedicine : Nanotechnology, Biology, and Medicine·Evan Rizzel GranDusica Maysinger
Aug 25, 2020·Journal of Medicinal Chemistry·Andrea ShergalisNouri Neamati
Dec 3, 2021·Molecular Oncology·Victor Ruiz-RodadoMioara Larion

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.